It usually resolves within the first month at each dose level
My doctor said new medicines are coming that might work even better. Thats where the next generation of medications comes in
(He left the company in 2003, in part because he felt the company didnt then prioritize obesity treatments or see the benefit of an injectable weight-loss drug.) Following a once-weekly subcutaneous injection of retatrutide, participants in clinical trials exhibited a significant reduction in body weight and improvement of metabolic markers. Data collected in a phase II trial showed that obese participants lost a mean average of 24.2 percent of their body weight over a 48-week period
A lower 4mg weekly dose also resulted in impressive weight loss results, with an average loss of 17% over 48 weeks and: 92% of participants lost at least 5% of their starting body weight 75% lost at least 10% of their body weight 60% lost at least 15% of their starting weight Retatrutide vs Mounjaro In clinical trials, the active ingredient in Mounjaro, tirzepatide, results in an average weight loss of 22.5% at the highest 15mg per week dose over 72 weeks
The incremental cost-effectiveness ratio was calculated based on the cost per quality-adjusted life-year (QALY) gained
If you are dealing with significant weight gain or advanced metabolic dysfunction and need a more aggressive intervention, Retatrutide may be worth considering under proper medical supervision